Explore Your Topic
Annual Report 2023 Image with Blue Background
Tuesday, March 05, 2024
FY/Q4 2023 Reporting
Latest News
Share Price / Index
February 26, 2024
Not intended for UK Media
Bayer receives U.S. FDA Breakthrough Therapy designation for BAY 2927088 for non-small cell lung cancer harboring HER2 activating mutations
February 19, 2024
Bayer plans to amend its dividend policy to reduce debt
January 24, 2024
Not intended for U.S. and UK Media
Application for regulatory approval of Aflibercept 8 mg accepted in China

Find Your Product

With our products we contribute to the health of people and plants. Here you find an overview of the major Bayer products.